IMAB
I-Mab
NASDAQ · Healthcare · Biotechnology · US
$2.88
−0.69%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-19.4%
Return on equity
-18.5%
Return on assets
-19.1%
Return on invested capital
0.00x
Asset turnover
$0.00
Cash from operations
$0.30
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2025